Go to the full article:
Wholesalers are asked to report key details on suspicious orders of controlled substances – The Script July 2018 p. 13 (a publication of the California State Board of Pharmacy)
“A wholesaler, upon discovery, shall notify the board in writing of any suspicious orders of controlled substances placed by a California-licensed pharmacy or wholesaler by providing the board a copy of the information that the wholesaler provides to the United States Drug Enforcement Administration. Suspicious orders include, but are not limited to, orders of unusual size, orders deviating substantially from a normal pattern, and orders of unusual frequency.”
The Board requests, ” . . . that reports include explicit information as to why the wholesaler deemed the order suspicious. For example, indicate if (1) the order was of an unusual size, (2) the order deviated substantially from the normal pattern, or (3) the order was of an unusual frequency.”
Reference: On Oct.
7, 2017, Governor Brown signed
into law Assembly Bill 401.
This bill added Business and
Professions Code section 4169.1
Go to DREprof.com: The Designated Representative and Exemptee Training Website
- California Designated Representative Training Course for Reverse Distributors
- California Designated Representative Training Course for 3PL
- California Designated Representative Training Course for Wholesalers – Available around-the-clock 24 x 7
- Florida Certified Designated Representative – CDR Law and Rules Exam Prep Course
- The Designated Representative Institute